Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 2, 2026
June 2, 2026
4ed1473e-e7aa-43b9-89a0-6a6910525833
Related Documents
Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management
Guidance DocumentOctober 27, 2026Center for Biologics Evaluation and Research
Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing
Guidance DocumentApril 14, 2026Center for Biologics Evaluation and Research
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.